Description
monkey dust drug (MDPHP) | Secured Tracked Logistics EU
monkey dust drugs (MDPHP)
Looking to secure a reliable supply of monkey dust drugs (MDPHP) to buy monkey dust drugs online for personal uses , forensic profiling, mass spectrometry calibration, or neuroreceptor transport assays? As a leading European chemical distributor, we deliver certified, premium-grade MDPHP synthesized under strict laboratory quality control parameters. When you buy MDPHP online through our encrypted portal, you receive a highly stable analytical reference standard optimized for in vitro testing.
We cater exclusively to corporate entities, academic institutions, and contract research organizations (CROs). Whether your project requires you to buy MDPHP online for retail gram quantities or a long-term bulk MDPHP supplier contract, our logistics network ensures consistent purity across every batch.
Technical Specifications & Product Identification Data
-
- Systematic IUPAC Nomenclature: 1-(1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)hexan-1-one
- Standard CAS Registry Number: 776994-64-0 (Base Form) | 24622-62-6 (Hydrochloride Salt Form)
- Molecular Formula: C₁₇H₂₃NO₃ · HCl (Refined Hydrochloride Form)
- Exact Molar Mass: 289.37 g/mol (Base) | 325.83 g/mol (Refined HCl Salt variant)
- Physical Presentation: Highly stable, fine white to off-white homogenous crystalline powder or aggregates
- Structural Classification: Pyrrolidinophenone synthetic cathinone derivative featuring a 3,4-methylenedioxy substitution on the phenyl ring core coupled with an extended six-carbon alkyl chain backbone.
Theoretical Pharmacology & Documented Adverse Effects
Before you buy MDPHP online, note that in vitro transport assays classify it as an exceptionally potent central nervous system stimulant. Mechanistically, it functions as a potent norepinephrine-dopamine reuptake inhibitor (NDRI). Due to the structural integration of the rigid pyrrolidine ring, it demonstrates an ultra-high affinity for blocking dopamine transporters (DAT) and norepinephrine transporters (NET) inside the synaptic cleft, with a negligible affinity for serotonin transporters (SERT).
Exposure triggers intense physiological and autonomic overstimulation. Documented systemic effects include acute tachycardia, heavy peripheral vasoconstriction, elevated blood pressure, severe appetite suppression, hyperthermia, and involuntary muscle tremors. Forensic tracking documentation indicates critical cardiotoxic stress, intense jaw clenching (bruxism), and a pronounced risk of drug-induced psychomotor agitation or acute psychosis if standard containment safeguards fail.
Legal Status & European Regulations
The international legal framework surrounding synthetic pyrrolidinophenones is zero-tolerance and heavily monitored:
-
- European Union (EU-Wide Prohibition): MDPHP is intensively monitored by the European Union Drugs Agency (EUDA) and is banned or heavily scheduled as an illicit substance across EU Member States. National frameworks—such as Germany’s NpSG (broad structural group ban) and equivalent narcotic acts in France, Poland, and the Netherlands—restrict distribution solely to state-authorized scientific installations holding specialized government permits.
- United Kingdom: Controlled rigidly under the Class B framework of the Misuse of Drugs Act 1971 and universally prohibited under the Psychoactive Substances Act 2016, criminalizing all forms of unauthorized supply, domestic transfer, or importation into British territory.
- Shipping Policy: Orders addressed to private residential zip codes or unauthorized territories will be delivered securely and discretely at your risk and responsibility.
Authorized Research Use & Safety Warning
The compound MDPHP is a synthetic substance classified strictly as an analytical reagent or laboratory reference standard. It is not intended for human or veterinary consumption. Ingestion or accidental exposure poses severe, life-threatening health risks and is illegal under various international and national drug control frameworks. By placing this item into your cart, please ensure that you check the legality status of any product you purchase on our website as we cannot be held responsible for it.
Frequently Asked Questions (FAQ)
What are the primary health risks associated with monkey dust drugs?
As a highly potent phenethylamine and pyrrolidinophenone derivative, exposure to MDPHP carries substantial cardiovascular and neurological risks. Documented adverse reactions include severe hypertensive strain, rapid heart rate (tachycardia), dangerous spikes in core body temperature (hyperthermia), peripheral vasoconstriction, severe paranoia, and profound psychomotor agitation. Prolonged exposure or high doses may lead to permanent organ damage or structural cardiovascular complications.
How does MDPHP differ structurally from MDPV?
The molecular structure of MDPHP is a direct higher homologue of MDPV (methylenedioxypyrovalerone). While MDPV features a valerophenone (five-carbon) alkyl chain backbone, MDPHP incorporates an extended hexiophenone (six-carbon) alkyl side chain. This structural lengthening modifies its lipophilicity and molecular clearance kinetics while maintaining its high-potency NDRI mechanism.
Is MDPHP legal for personal use?
No. In the majority of jurisdictions, including the European Union and the United Kingdom, MDPHP is a heavily controlled substance. Unauthorized possession, supply, or importation is a criminal offense. Legal access is strictly limited to authorized scientific research institutions and requires specialized permits for forensic or legitimate laboratory research purposes.
